Zhitong Finance App News, Jianshi Technology-B (09877.HK) announced that the company's transduced tricuspid valve replacement system LUX-Valve Plus has recently obtained approval from the Department of Health of the Hong Kong Special Administrative Region of the People's Republic of China, and the company is actively promoting the commercialization of this product in Hong Kong, China.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.